UniSuper Management Pty Ltd Acquires New Shares in Doximity, Inc. $DOCS

Key Points

• UniSuper Management Pty Ltd has acquired a new stake in Doximity, Inc., purchasing 36,036 shares valued at approximately $2.09 million.
• Doximity's quarterly earnings surpassed estimates, reporting $0.36 earnings per share, which is $0.05 above the consensus estimate of $0.31.
• Institutional investors collectively own 87.19% of Doximity's stock, indicating strong institutional interest in the company.

UniSuper Management Pty Ltd acquired a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 36,036 shares of the company's stock, valued at approximately $2,091,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Parkman Healthcare Partners LLC bought a new stake in Doximity in the first quarter valued at approximately $5,426,000. NewEdge Advisors LLC raised its stake in Doximity by 613.7% in the first quarter. NewEdge Advisors LLC now owns 6,323 shares of the company's stock valued at $367,000 after buying an additional 5,437 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Doximity by 0.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock valued at $2,262,000 after buying an additional 210 shares during the period. Integrated Wealth Concepts LLC raised its stake in Doximity by 133.1% in the first quarter. Integrated Wealth Concepts LLC now owns 31,187 shares of the company's stock valued at $1,810,000 after buying an additional 17,807 shares during the period. Finally, Eventide Asset Management LLC bought a new stake in Doximity in the first quarter valued at approximately $554,000. Institutional investors own 87.19% of the company's stock.

Analysts Set New Price Targets

DOCS has been the topic of a number of recent research reports. Robert W. Baird increased their target price on Doximity from $75.00 to $80.00 and gave the stock an "outperform" rating in a research note on Thursday. Evercore ISI upgraded Doximity from an "in-line" rating to an "outperform" rating and increased their target price for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. Zacks Research lowered Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Piper Sandler increased their target price on Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Finally, BTIG Research upgraded Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price on the stock in a research note on Monday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat.com, Doximity currently has an average rating of "Moderate Buy" and an average target price of $67.00.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the sale, the director owned 6,360 shares of the company's stock, valued at approximately $381,600. This trade represents a 61.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director directly owned 16,618 shares in the company, valued at approximately $948,721.62. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,000 shares of company stock worth $1,929,380 in the last 90 days. Company insiders own 31.30% of the company's stock.

Doximity Price Performance

Doximity stock traded up $0.79 during mid-day trading on Friday, reaching $71.05. 1,374,597 shares of the company were exchanged, compared to its average volume of 2,224,099. The company has a fifty day simple moving average of $63.60 and a 200-day simple moving average of $59.92. Doximity, Inc. has a 12 month low of $38.30 and a 12 month high of $85.21. The firm has a market cap of $13.31 billion, a PE ratio of 71.05, a PEG ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter last year, the firm posted $0.28 EPS. The business's quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Sell-side analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.